Prior use of durable medical equipment as a risk adjuster for health-based capitation

Inquiry

Volumn 47, Issue 4, 2011, Pages 343-358

  van Kleef, Richard C ^a   van Vliet, René C J A ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CAPITATION FEE; ECONOMICS; FEMALE; HEALTH CARE COST; HUMAN; MALE; MEDICAL INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; NETHERLANDS; PUBLIC HEALTH; RISK ASSESSMENT; STATISTICS;

ADULT; CAPITATION FEE; DURABLE MEDICAL EQUIPMENT; FEMALE; HEALTH EXPENDITURES; HUMANS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; NETHERLANDS; RISK ADJUSTMENT;

EID: 79953211154     PISSN: 00469580     EISSN: None     Source Type: Journal    
DOI: 10.5034/inquiryjrnl_47.04.343     Document Type: Article

References (18)

1. Fishman, P. A., M. J. Goodman, M. C. Hornbrook, R. T. Meenan, D. J. Bachman, and M. C. O'Keeffe Rosetti. 2003. Risk Adjustment Using Automated Ambulatory Pharmacy Data: The RxRisk Model. Medical Care 41(1):84-99.
2. Greenwald, L. M., A. Esposito, M. J. Ingber, and J. M. Levy. 1998. Risk Adjustment for the Medicare Program: Lessons Learned from Research and Demonstrations. Inquiry 35(2): 193-209.
3. Hornbrook, M. C., and M. J. Goodman. 1996. Chronic Disease, Functional Health Status, and Demographics: A Multi-Dimensional Approach to Risk Adjustment. Health Services Research 31(3):283-307.
4. Kautter, J., M. Ingber, and G. C. Pope. 2009. Medicare Risk Adjustment for the Frail Elderly. Health Care Financing Review 30(2): 83-93.
5. Kronick, R., T. Gilmer, T. Dreyfus, and L. Lee. 2000. Improving Health-Based Payments for Medicaid Beneficiaries: CDPS. Health Care Financing Review 21(3):29-64.
6. Lamers, L. M. 1998. Risk-Adjusted Capitation Payments: Developing a Diagnostic Cost Groups Classification for the Dutch Situation. Health Policy 45(1):15-32.
7. Lamers, L. M. 1999. Pharmacy Cost Groups: A Risk-Adjuster for Capitation Payments Based on the Use of Prescribed Drugs. Medical Care 37(8):824-830.
8. Lamers, L. M. 2001. Health-Based Risk Adjustment: Is Inpatient and Outpatient Diagnostic Information Sufficient? Inquiry 38(4):423-431.
9. Newhouse, J. P. 1998. Risk Adjustment: Where Are We Now? Inquiry 35(2):122-129.
10. Noyes, K., L. Hangsheng, and H. Temkin-Greener. 2008. Medicare Capitation Model, Functional Status and Multiple Comorbidities: Model Accuracy. American Journal of Managed Care 14(10):679-690.
11. Pope, G. C., R. P. Ellis, A. S. Ash, J. Z. Ayanian, D. W. Bates, H. Burstin, L. I. Iezzoni, E. Marcantonio, and B. Wu. 2000a. Diagnostic Cost Group Hierarchical Condition Category Models for Medicare Risk Adjustment. Final Report prepared for the Health Care Financing Administration.
12. Pope, G. C., R. P. Ellis, A. S. Ash, C. F. Liu, J. Z. Ayanian, D. W. Bates, H. Burstin, L. I. Iezzoni, and M. J. Ingber. 2000b. Principal Inpatient Diagnostic Cost Group Model for Medicare Risk Adjustment. Health Care Financing Review 21(3):93-118.
13. Pope, G. C., J. Kautter, R. P. Ellis, A. S. Ash, J. Z. Ayanian, L. I. Iezzoni, M. J. Ingber, J. M. Levy, and J. Robst. 2004. Risk Adjustment of Medicare Capitation Payments Using the CMS-HCC Model. Health Care Financing Review 25(4):119-141.
14. Pope, G. C., K. W. Adamache, E. G. Walsh, and R. K. Khandker. 1998. Evaluation Alternative Risk Adjusters for Medicare. Health Care Financing Review 20(2):109-129.
15. Prinsze, F. J., and R. C. J. A. van Vliet. 2007. Health-Based Risk Adjustment: Improving the Pharmacy-Based Cost Group Model by Adding Diagnostic Cost Groups. Inquiry 44(4): 469-480.
16. Stam, P. J. A., and W. P. M. M. van de Ven. 2007. Evaluatie Risicoverevening: Prikkels tot Risicoselectie? Een Evaluatie van het Vereveningsmodel 2007 en Oplossingsrichtingen voor Verbetering. (Evaluation Risk Equalization: Incentives for Risk Selection? An Evaluation of the 2007 Risk Equalization Model and Possibilities for Improvement.) Dutch Research Report. Rotterdam, The Netherlands: Erasmus University.
17. Van Barneveld, E. M., R. C. J. A. van Vliet, and W. P. M. M. van de Ven. 2001. Risk Sharing Between Competing Health Plans and Sponsors. Health Affairs 20(3):253-262.
18. Zhao, Y., A. S. Ash, R. P. Ellis, J. Z. Ayanian, G. C. Pope, B. Bowen, and L. Weyuker. 2005. Predicting Pharmacy Costs and Other Medical Costs Using Diagnoses and Drug Claims. Medical Care 43(1):34-43.